Holen Sie sich die Stockscreener-App
6.46
0.15%
-0.010
Handel nachbörslich:
6.29
-0.17
-2.63%
Schlusskurs vom Vortag:
$6.47
Offen:
$6.42
24-Stunden-Volumen:
38,477
Relative Volume:
0.03
Marktkapitalisierung:
$5.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.77M
KGV:
-0.00491
EPS:
-1316.2474
Netto-Cashflow:
$-14.37M
1W Leistung:
-2.71%
1M Leistung:
-12.70%
6M Leistung:
+3,729%
1J Leistung:
-81.44%
1-Tages-Spanne:
$6.2905
$6.47
1-Wochen-Bereich:
$6.2905
$7.4999
52-Wochen-Spanne:
$0.0927
$48.80
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Vergleichen Sie GCTK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
6.46 | 5.89M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
544.21 | 189.40B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.30 | 51.22B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
ALC
Alcon Inc
|
73.88 | 36.53B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
RMD
Resmed Inc
|
248.95 | 36.04B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
WST
West Pharmaceutical Services Inc
|
279.78 | 20.29B | 2.96B | 487.70M | 344.00M | 6.6758 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
GlucoTrack Announces Special Shareholders Meeting for Equity Deal - TipRanks
Glucotrack, Inc. Encourages Shareholders to Vote on Equity Purchase Agreement - TradingView
Glucotrack, Inc. Encourages Shareholders to Vote - The Manila Times
Glucotrack (NASDAQ: GCTK) sets Nov 7 meeting to vote on more than 20% share issuance - Stock Titan
How GlucoTrack Inc. stock reacts to bond yieldsPortfolio Profit Report & Weekly Hot Stock Watchlists - newser.com
Key resistance and support levels for GlucoTrack Inc.July 2025 Levels & Real-Time Stock Movement Alerts - newser.com
Does GlucoTrack Inc. stock trade at a discount to peers2025 Major Catalysts & Real-Time Stock Entry Alerts - newser.com
GlucoTrack Inc. stock daily chart insightsQuarterly Market Review & Smart Allocation Stock Tips - newser.com
Technical analysis overview for GlucoTrack Inc. stock2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
How GlucoTrack Inc. stock reacts to job market dataBond Market & AI Forecasted Entry and Exit Points - newser.com
Can machine learning forecast GlucoTrack Inc. recoveryJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
How interest rate cuts could boost GlucoTrack Inc. stockJuly 2025 Decliners & Weekly High Potential Stock Alerts - newser.com
GlucoTrack Inc trading resumes - MSN
GCTK registers 20,060,000 shares for Sixth Borough resale - Stock Titan
What drives GlucoTrack Inc stock priceIPO Market Watch & Build Wealth With Zero-Cost Tools - earlytimes.in
GlucoTrack Inc trading halted, volatility trading pause - MSN
Glucotrack’s Innovative Glucose Sensor Study: A Potential Game-Changer for Diabetes Management - MSN
GlucoTrack Appoints Dr. Usman Latif to Advisory Team - TipRanks
Glucotrack, Inc. Appoints Usman Latif to Clinical Advisory Team - TradingView
[8-K] Glucotrack, Inc. Reports Material Event | GCTK SEC FilingForm 8-K - Stock Titan
Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team - The Manila Times
Glucotrack (NASDAQ: GCTK) taps Dr. Usman Latif to guide epidural glucose monitoring - Stock Titan
GlucoTrack Announces Special Shareholder Meeting for Equity Vote - TipRanks
Glucotrack, Inc. Announces Special Shareholder Meeting - TradingView
GCTK files 8-K; Regulation FD press release furnished (Ex. 99.1) - Stock Titan
Glucotrack, Inc. Reminds Shareholders to Vote - The Manila Times
How to read the order book for GlucoTrack Inc.July 2025 Levels & Risk Controlled Daily Plans - newser.com
Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement - Stock Titan
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.41%
0.47%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):